Literature DB >> 23264655

The crystal structure of human soluble CD14 reveals a bent solenoid with a hydrophobic amino-terminal pocket.

Stacy L Kelley1, Tiit Lukk, Satish K Nair, Richard I Tapping.   

Abstract

Human monocyte differentiation Ag CD14 is a pattern recognition receptor that enhances innate immune responses to infection by sensitizing host cells to bacterial LPS (endotoxin), lipoproteins, lipoteichoic acid, and other acylated microbial products. CD14 physically delivers these lipidated microbial products to various TLR signaling complexes that subsequently induce intracellular proinflammatory signaling cascades upon ligand binding. The ensuing cellular responses are usually protective to the host but can also result in host fatality through sepsis. In this work, we have determined the x-ray crystal structure of human CD14. The structure reveals a bent solenoid typical of leucine-rich repeat proteins with an amino-terminal pocket that presumably binds acylated ligands including LPS. Comparison of human and mouse CD14 structures shows great similarity in overall protein fold. However, compared with mouse CD14, human CD14 contains an expanded pocket and alternative rim residues that are likely to be important for LPS binding and cell activation. The x-ray crystal structure of human CD14 presented in this article may foster additional ligand-bound structural studies, virtual docking studies, and drug design efforts to mitigate LPS-induced sepsis and other inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23264655      PMCID: PMC3552104          DOI: 10.4049/jimmunol.1202446

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  92 in total

Review 1.  Soluble CD14-mediated cellular responses to lipopolysaccharide.

Authors:  R I Tapping; P S Tobias
Journal:  Chem Immunol       Date:  2000

2.  Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components.

Authors:  O Takeuchi; K Hoshino; T Kawai; H Sanjo; H Takada; T Ogawa; K Takeda; S Akira
Journal:  Immunity       Date:  1999-10       Impact factor: 31.745

Review 3.  Lipopolysaccharide endotoxins.

Authors:  Christian R H Raetz; Chris Whitfield
Journal:  Annu Rev Biochem       Date:  2001-11-09       Impact factor: 23.643

4.  Structure-function analysis of CD14 as a soluble receptor for lipopolysaccharide.

Authors:  S Viriyakosol; J C Mathison; P S Tobias; T N Kirkland
Journal:  J Biol Chem       Date:  2000-02-04       Impact factor: 5.157

5.  Discrimination of bacterial lipoproteins by Toll-like receptor 6.

Authors:  O Takeuchi; T Kawai; P F Mühlradt; M Morr; J D Radolf; A Zychlinsky; K Takeda; S Akira
Journal:  Int Immunol       Date:  2001-07       Impact factor: 4.823

6.  Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition.

Authors:  S Akashi; Y Nagai; H Ogata; M Oikawa; K Fukase; S Kusumoto; K Kawasaki; M Nishijima; S Hayashi; M Kimoto; K Miyake
Journal:  Int Immunol       Date:  2001-12       Impact factor: 4.823

7.  Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products.

Authors:  E Lien; T J Sellati; A Yoshimura; T H Flo; G Rawadi; R W Finberg; J D Carroll; T Espevik; R R Ingalls; J D Radolf; D T Golenbock
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

8.  [Clone and expression of human soluble CD14 and study of its function].

Authors:  J Bai; J Yin; Z D Wang; W Wang; Z Z Wang; W Song
Journal:  Sheng Wu Gong Cheng Xue Bao       Date:  2001-05

9.  Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion.

Authors:  A B Schromm; K Brandenburg; H Loppnow; A P Moran; M H Koch; E T Rietschel; U Seydel
Journal:  Eur J Biochem       Date:  2000-04

Review 10.  ML -- a conserved domain involved in innate immunity and lipid metabolism.

Authors:  Naohiro Inohara; Gabriel Nuñez
Journal:  Trends Biochem Sci       Date:  2002-05       Impact factor: 13.807

View more
  33 in total

Review 1.  The critical role of toll-like receptors--From microbial recognition to autoimmunity: A comprehensive review.

Authors:  Maximiliano Javier Jiménez-Dalmaroni; M Eric Gerswhin; Iannis E Adamopoulos
Journal:  Autoimmun Rev       Date:  2015-08-20       Impact factor: 9.754

2.  Human lipopolysaccharide-binding protein (LBP) and CD14 independently deliver triacylated lipoproteins to Toll-like receptor 1 (TLR1) and TLR2 and enhance formation of the ternary signaling complex.

Authors:  Diana Rose E Ranoa; Stacy L Kelley; Richard I Tapping
Journal:  J Biol Chem       Date:  2013-02-19       Impact factor: 5.157

3.  Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.

Authors:  Naoki Okamoto; Keisuke Mizote; Hiroe Honda; Akinori Saeki; Yasuharu Watanabe; Tomomi Yamaguchi-Miyamoto; Ryutaro Fukui; Natsuko Tanimura; Yuji Motoi; Sachiko Akashi-Takamura; Tatsuhisa Kato; Shigeto Fujishita; Takahito Kimura; Umeharu Ohto; Toshiyuki Shimizu; Takatsugu Hirokawa; Kensuke Miyake; Koichi Fukase; Yukari Fujimoto; Yoshinori Nagai; Kiyoshi Takatsu
Journal:  J Biol Chem       Date:  2017-07-28       Impact factor: 5.157

4.  Fasciola hepatica fatty acid binding protein inhibits TLR4 activation and suppresses the inflammatory cytokines induced by lipopolysaccharide in vitro and in vivo.

Authors:  Ivelisse Martin; Kimberly Cabán-Hernández; Olgary Figueroa-Santiago; Ana M Espino
Journal:  J Immunol       Date:  2015-03-16       Impact factor: 5.422

5.  Type 1 piliated uropathogenic Escherichia coli hijack the host immune response by binding to CD14.

Authors:  Kathrin Tomasek; Alexander Leithner; Ivana Glatzova; Michael S Lukesch; Calin C Guet; Michael Sixt
Journal:  Elife       Date:  2022-07-26       Impact factor: 8.713

6.  Studies of the TLR4-associated protein MD-2 using yeast-display and mutational analyses.

Authors:  Daiva M Mattis; Adam S Chervin; Diana R Ranoa; Stacy L Kelley; Richard I Tapping; David M Kranz
Journal:  Mol Immunol       Date:  2015-08-28       Impact factor: 4.407

7.  Monophosphoryl lipid A-induced pro-inflammatory cytokine expression does not require CD14 in primary human dendritic cells.

Authors:  Sonja T H M Kolanowski; Suzanne N Lissenberg-Thunnissen; Diba Emal; S Marieke van Ham; Anja Ten Brinke
Journal:  Inflamm Res       Date:  2016-03-18       Impact factor: 4.575

8.  Chimeric anti-CD14 IGG2/4 Hybrid antibodies for therapeutic intervention in pig and human models of inflammation.

Authors:  Corinna Lau; Kristin S Gunnarsen; Lene S Høydahl; Jan Terje Andersen; Gøril Berntzen; Anne Pharo; Julie K Lindstad; Judith K Ludviksen; Ole-Lars Brekke; Andreas Barratt-Due; Erik Waage Nielsen; Christopher R Stokes; Terje Espevik; Inger Sandlie; Tom Eirik Mollnes
Journal:  J Immunol       Date:  2013-09-23       Impact factor: 5.422

9.  Crystal structure of an anti-idiotype variable lymphocyte receptor.

Authors:  Bernard C Collins; Hiro Nakahara; Sharmistha Acharya; Max D Cooper; Brantley R Herrin; Ian A Wilson
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2017-11-14       Impact factor: 1.056

10.  Mechanisms of Toll-like Receptor 4 Endocytosis Reveal a Common Immune-Evasion Strategy Used by Pathogenic and Commensal Bacteria.

Authors:  Yunhao Tan; Ivan Zanoni; Thomas W Cullen; Andrew L Goodman; Jonathan C Kagan
Journal:  Immunity       Date:  2015-11-03       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.